Home › Disorders of Excessive Somnolence › South Carolina › Columbia
Disorders of Excessive Somnolence clinical trials in Columbia, SC
7 studies for Disorders of Excessive Somnolence are looking for participants at sites in and around Columbia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
RecruitingPhase 2/3
- Columbia, South Carolina, Columbia
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
RecruitingPhase 3
- Bogan Sleep Consultants, LLC, Columbia
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
RecruitingPhase 3
- Alkermes Investigational Site, Columbia
A Phase 3 Study to Evaluate the Efficacy and Safety of Samelisant in Patients With Narcolepsy (AWAKE)
RecruitingPhase 3
- Bogan Sleep Consultants, Columbia
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
RecruitingPhase 3
- Alkermes Investigational Site, Columbia
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
RecruitingPhase 2/3
- Alkermes Investigational Site, Columbia
Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
RecruitingPhase 3
- Clinical Research Site, Columbia
Disorders of Excessive Somnolence trials in other cities
- Cincinnati, OH9 studies
- San Antonio, TX9 studies
- Atlanta, GA9 studies
- Miami, FL8 studies
- Charlotte, NC8 studies
- Austin, TX7 studies
- Sugar Land, TX7 studies
- Orlando, FL7 studies
- Brandon, FL6 studies
- Los Angeles, CA5 studies
- Macon, GA5 studies
- Reading, PA5 studies
Other studies in Columbia
- Obesity9 studies
- Overweight8 studies
- Stroke7 studies
- Narcolepsy6 studies
- Cardiovascular Disease6 studies
- Macular Degeneration6 studies
- Steatotic Liver Disease5 studies
- Burkitt Lymphoma5 studies
- High Blood Pressure5 studies
- Heart Failure5 studies
- Aphasia5 studies
- Idiopathic Hypersomnia5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.